Myelo001

Myelo001 · Myelo Therapeutics GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Myelo001, covering 2017-11-24 to 2017-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia [Phase 2]